BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26423325)

  • 1. F11 is associated with recurrent VTE in women. A prospective cohort study.
    Bruzelius M; Ljungqvist M; Bottai M; Bergendal A; Strawbridge RJ; Holmström M; Silveira A; Kieler H; Hamsten A; Lärfars G; Odeberg J
    Thromb Haemost; 2016 Jan; 115(2):406-14. PubMed ID: 26423325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors.
    Bruzelius M; Bottai M; Sabater-Lleal M; Strawbridge RJ; Bergendal A; Silveira A; Sundström A; Kieler H; Hamsten A; Odeberg J
    J Thromb Haemost; 2015 Feb; 13(2):219-27. PubMed ID: 25472531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.
    Småbrekke B; Rinde LB; Evensen LH; Morelli VM; Hveem K; Gabrielsen ME; Njølstad I; Mathiesen EB; Rosendaal FR; Braekkan SK; Hansen JB
    J Thromb Haemost; 2019 Aug; 17(8):1363-1371. PubMed ID: 31124268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism risk associated with ABO, F11 and FGG loci.
    Manco L; Silva C; Fidalgo T; Martinho P; Sarmento AB; Ribeiro ML
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):528-532. PubMed ID: 29995659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study.
    Rinde LB; Morelli VM; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Wilsgaard T; Smith E; Rosendaal FR; Frazer KA; Braekkan SK; Hansen JB
    J Thromb Haemost; 2019 May; 17(5):749-758. PubMed ID: 30773804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
    Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA
    Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
    Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
    Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event.
    Skille H; Paulsen B; Hveem K; Gabrielsen ME; Brumpton B; Hindberg K; Gran OV; Rosendaal FR; Braekkan SK; Hansen JB
    J Thromb Haemost; 2020 Nov; 18(11):2861-2869. PubMed ID: 32671915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of F11 polymorphism rs2289252 with deep vein thrombosis and related phenotypes in population of Latvia.
    Rovite V; Maurins U; Megnis K; Vaivade I; Pečulis R; Rits J; Prave S; Klovins J
    Thromb Res; 2014 Sep; 134(3):659-63. PubMed ID: 25091233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of prothrombin 19911 A>G polymorphism, blood group and male gender in patients with venous thromboembolism: Results of a German cohort study.
    Limperger V; Kenet G; Kiesau B; Köther M; Schmeiser M; Langer F; Juhl D; Shneyder M; Franke A; Klostermeier UK; Mesters R; Rühle F; Stoll M; Steppat D; Kowalski D; Rocke A; Kuta P; Bajorat T; Torge A; Neuner B; Junker R; Nowak-Göttl U
    J Thromb Thrombolysis; 2021 Feb; 51(2):494-501. PubMed ID: 32594420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Risk of Venous Thromboembolism Attributed to Established Prothrombotic Genotypes.
    Evensen LH; Arnesen CAL; Rosendaal FR; Gabrielsen ME; Brumpton BM; Hveem K; Hansen JB; Brækkan SK
    Thromb Haemost; 2022 Jul; 122(7):1221-1230. PubMed ID: 34784644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations associated with recurrent venous thrombosis.
    van Hylckama Vlieg A; Flinterman LE; Bare LA; Cannegieter SC; Reitsma PH; Arellano AR; Tong CH; Devlin JJ; Rosendaal FR
    Circ Cardiovasc Genet; 2014 Dec; 7(6):806-13. PubMed ID: 25210051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.
    Jarvis KB; LeBlanc M; Tulstrup M; Nielsen RL; Albertsen BK; Gupta R; Huttunen P; Jónsson ÓG; Rank CU; Ranta S; Ruud E; Saks K; Trakymiene SS; Tuckuviene R; Schmiegelow K
    Thromb Res; 2019 Dec; 184():92-98. PubMed ID: 31715544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study.
    Horvei LD; Braekkan SK; Smith EN; Solomon T; Hindberg K; Frazer KA; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2018 Jan; 16(1):83-89. PubMed ID: 29094466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint Effect of Multiple Prothrombotic Genotypes and Obesity on the Risk of Incident Venous Thromboembolism.
    Frischmuth T; Hindberg K; Gabrielsen ME; Brumpton B; Hveem K; Brækkan SK; Hansen JB; Morelli VM
    Thromb Haemost; 2022 Feb; 122(2):267-276. PubMed ID: 33940655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Risk Profiling Associated with Recurrent Unprovoked Venous Thromboembolism.
    Hodeib H; Youssef A; Allam AA; Selim A; Tawfik MA; Abosamak MF; Esam A; Abd Elghafar MS; Samir S; ELshora OA
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Folsom AR; Tang W; Roetker NS; Heckbert SR; Cushman M; Pankow JS
    Am J Hematol; 2015 Nov; 90(11):1047-51. PubMed ID: 26260105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilocus genetic risk scores for venous thromboembolism risk assessment.
    Soria JM; Morange PE; Vila J; Souto JC; Moyano M; Trégouët DA; Mateo J; Saut N; Salas E; Elosua R
    J Am Heart Assoc; 2014 Oct; 3(5):e001060. PubMed ID: 25341889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for recurrent venous thromboembolism in young and middle-aged women.
    Ljungqvist M; Sonnevi K; Bergendal A; Holmström M; Kieler H; Lärfars G
    Thromb Res; 2014 May; 133(5):762-7. PubMed ID: 24613699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study.
    Sundquist K; Sundquist J; Svensson PJ; Zöller B; Memon AA
    J Thromb Haemost; 2015 Dec; 13(12):2180-6. PubMed ID: 26407905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.